Michael Ortiz, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Ortiz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05985161 · A Study of Selinexor in People With Wilms Tumors and Other Solid TumorsMemorial Sloan Kettering Cancer Center · recruiting · Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors · principal investigator
- Ph1NCT04928677 · A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After TreatmentMemorial Sloan Kettering Cancer Center · recruiting · Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3) · principal investigator
- Ph2NCT04671901 · A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid TumorsMemorial Sloan Kettering Cancer Center · terminated · Solid Tumor, Solid Tumor, Childhood, Solid Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in atypical teratoid rhabdoid tumour (at/rt).